EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Recent advances in zinc oxide -based nanostructures for anticancer research on human cell lines

A Surya Mary, Gopika Sabu, Rachel Reena Philip

Medical Oncology · 09.11.2026 · 43 (12)

DOI: 10.1007/s12032-026-03479-0 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Medical Oncology, online erschienen am 09.11.2026. Verfasst von A Surya Mary und 2 weiteren Autor:innen. Beteiligte Einrichtung: Thin Film Research Lab, Department of Physics, Union Christian College, Aluva, Kerala, India. Hauptthemen laut MEDLINE: Zinc Oxide, Antineoplastic Agents, Nanostructures, Neoplasms. Die Arbeit nennt 173 Literaturangaben. Gefördert von: Department of Science and Technology, Ministry of Science and Technology, India, Kerala State Council for Science, Technology and Environment.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This review critically surveys recent progress in the application of zinc oxide nanostructures (ZnO NS) for cancer therapy and anticancer drug delivery. It systematically examines how rational modification strategies such as elemental doping, surface functionalization, and drug loading, enhance therapeutic efficacy across cancers affecting fourteen human organs, with comparative evaluation across multiple cancer cell lines for each. Key in vitro assays and quantitative performance metrics, such as cell viability, IC₅₀, and selectivity index, are discussed to benchmark treatment effectiveness. Available in vivo studies are reviewed to understand the current preclinical status. The review highlights mechanistic correlations between enhanced anticancer activity and reactive oxygen species generation, apoptosis induction, and intracellular Zn²⁺ ion release. Biocompatibility considerations are critically assessed to address safety and translational potential, while molecular docking studies are integrated to provide molecular-level insights into interactions with cancer-related biomolecular targets. Collectively, this review consolidates current knowledge and provides guidance for the rational design, biological evaluation, drug delivery applications, and future development of ZnO-based nanostructures for effective cancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Zinc OxideAntineoplastic AgentsNanostructuresNeoplasmsHumansDrug Delivery SystemsCell Line, TumorAnimals

Stichwörter der Autor:innen

AnticancerCytotoxicityDrug deliveryMolecular dockingZnO nanostructure

Substanzen

Zinc OxideAntineoplastic Agents

Autor:innen und Institutionen

  • Thin Film Research Lab, Department of Physics, Union Christian College, Aluva, Kerala, India.
  • Srinivasa Ramanujan Institute for Basic Sciences, Velloor PO, Pampady, Kottayam, India.
  • Thin Film Research Lab, Department of Physics, Union Christian College, Aluva, Kerala, India. reenatara@gmail.com.
  • Srinivasa Ramanujan Institute for Basic Sciences, Velloor PO, Pampady, Kottayam, India. reenatara@gmail.com.

Förderung

  • Department of Science and Technology, Ministry of Science and Technology, India
  • Kerala State Council for Science, Technology and Environment

Zitieren

APA

Surya Mary, A., Sabu, G., & Philip, R. R. (2026). Recent advances in zinc oxide -based nanostructures for anticancer research on human cell lines. Medical Oncology, 43(12). https://doi.org/10.1007/s12032-026-03479-0

Vancouver

Surya Mary A, Sabu G, Philip RR. Recent advances in zinc oxide -based nanostructures for anticancer research on human cell lines. Medical Oncology. 2026;43(12). doi:10.1007/s12032-026-03479-0

BibTeX
@article{SuryaMary2026,
  author = {Surya Mary, A and Sabu, Gopika and Philip, Rachel Reena},
  title = {Recent advances in zinc oxide -based nanostructures for anticancer research on human cell lines},
  journal = {Medical Oncology},
  year = {2026},
  volume = {43},
  number = {12},
  doi = {10.1007/s12032-026-03479-0}
}
Kostenlos starten →